BiotechTube
Home/Tandem Diabetes/John Sheridan
JS

John Sheridan

President and Chief Executive Officer

Tandem Diabetes

Therapeutic Areas

Diabetes Mellitus, Type 1Diabetes Mellitus, Type 2

Tandem Diabetes Pipeline

DrugIndicationPhase
Control-IQ+ Algorithm RefinementsType 1 & Type 2 DiabetesCommercial
Tandem Mobi System RolloutType 1 & Type 2 Diabetes (U.S.)Commercial Launch
iOS Compatibility for MobiType 1 & Type 2 DiabetesDevelopment
CGM Integrations (Dexcom, Abbott)Diabetes ManagementPartnership
Pediatric Indications (<2 years)Type 1 DiabetesResearch

Leadership Team at Tandem Diabetes

LV
Leigh Vosseller
Chief Financial Officer
View full Tandem Diabetes profile